GA
DFTX

Guerra Advisors’s Definium Therapeutics DFTX Stock Holding History

Guerra Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$778 Buy
+66
New +$616 ﹤0.01% 723

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Guerra Advisors's DFTX Position: Q3 2025 in Review

Guerra Advisors opened a new position in Definium Therapeutics (DFTX) in Q3 2025: 66 shares worth $778. The stake represents ﹤0.01% of the portfolio and ranks #723 among its holdings.

195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • Guerra Advisors held 66 shares of Definium Therapeutics worth $778 as of Q3 2025.
  • Definium Therapeutics was a new Guerra Advisors position in Q3 2025.
  • Definium Therapeutics made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #723 holding.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.